Unintended changes to a genome, away from the desired target site, which occur as a consequence of genome editing.
A CRISPR-based treatment for sickle cell disease is one step closer to approval after an advisory committee for the US Food and Drug Administration met to review its safety...
The latest genome editing approaches and treatments, as well as ethical issues and equitable access, were discussed at the Third International Summit on Human Genome Editing...
A new deep-learning technology can design artificial proteins, called zinc fingers, to bind with any stretch of DNA in the human genome and modify gene expression...
A CRISPR-based form of genome editing that can replace entire genes may offer a new way to treat some genetic diseases...
CRISPR has been used to eliminate the toxic protein build-up associated with Huntington's disease in mice...
Synthetic DNA technology has been used to develop artificial genes, demonstrating how cells in an embryo are directed where to migrate and what cell type to become...
Full-term mouse offspring were derived from single unfertilised eggs using targeted CRISPR/Cas9 epigenome editing...
Two prominent Chinese bioethicists have recommend the jailed scientist, Dr He Jiankui, be made financially, morally and legally responsible for the health and wellbeing of the children he genome-edited...
The Centre for Bioethics and Harvard Medical School, Massachusetts, presented a fascinating talk on the opportunities for great medical advancements, and grave harm, presented to researchers by CRISPR/Cas9 and other apporaches to genome editing...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
